Ipca Laboratories Limited
NSE: IPCALAB · Healthcare
₹1,928.50
+8.10 (+0.42%)
Last close · 30 Aug 2026, 11:53 am IST
- Open
- ₹1,916.00
- Day high
- ₹1,958.60
- Day low
- ₹1,911.60
- Volume
- 4.28 L
- Prev close
- ₹1,920.40
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty HealthcareNifty Midcap 150Nifty MidSmallcap 400Nifty Pharma
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 44,720 Cr
- Price
- 1,762.70
- P/E (TTM)
- 39.21
- P/E (Fwd)
- 26.85
- P/B
- 5.55
- EV/EBITDA
- 22.79
- EV/Revenue
- 4.75
- PEG
- —
- Div Yield
- 0.34%
- 52W High
- 1,944.90
- 52W Low
- 1,251.60
- Beta
- 0.05
Profitability & income
- Revenue (TTM)
- 9,647 Cr
- Net Income (TTM)
- 1,141 Cr
- EBITDA
- 2,009 Cr
- Gross Margin
- 67.23%
- Op. Margin
- 18.47%
- Net Margin
- 11.83%
- ROE
- 13.22%
- ROA
- 8.42%
- EPS (TTM)
- 44.95
- EPS (Fwd)
- 65.66
Financial health
- Total Debt
- 809 Cr
- Total Cash
- 1,196 Cr
- Debt/Equity
- 8.49
- Current Ratio
- 2.76
- Quick Ratio
- 1.48
- Book Value
- 317.84
- Free Cash Flow
- 790 Cr
- Op. Cash Flow
- 1,142 Cr
Growth
- Revenue Growth
- 6.30%
- Earnings Growth
- 341.60%
- Earnings QoQ
- 341.00%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2,388 Cr | 299 Cr | 532 Cr | 377 Cr | 1,697 Cr | — | 809 Cr | 8,064 Cr |
| 2025-12-31 | 2,393 Cr | 326 Cr | 571 Cr | 426 Cr | 1,735 Cr | — | — | — |
| 2025-09-30 | 2,557 Cr | 283 Cr | 515 Cr | 442 Cr | 1,775 Cr | — | 1,279 Cr | 7,427 Cr |
| 2025-06-30 | 2,309 Cr | 233 Cr | 449 Cr | 316 Cr | 1,617 Cr | — | — | — |
| 2025-03-31 | 2,247 Cr | 68 Cr | 250 Cr | 329 Cr | 1,538 Cr | — | 1,363 Cr | 6,948 Cr |
| 2024-12-31 | — | — | — | — | — | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 9,563 Cr | 1,141 Cr | 2,066 Cr | 1,630 Cr | 6,582 Cr | 1,142 Cr | 809 Cr | 8,064 Cr |
| 2025-03-31 | 8,855 Cr | 738 Cr | 1,613 Cr | 1,356 Cr | 5,924 Cr | 1,321 Cr | 1,363 Cr | 6,948 Cr |
| 2024-03-31 | 7,622 Cr | 547 Cr | 1,337 Cr | 934 Cr | 4,897 Cr | 945 Cr | 1,438 Cr | 6,332 Cr |
| 2023-03-31 | 6,207 Cr | 471 Cr | 1,052 Cr | 705 Cr | 3,799 Cr | 806 Cr | 1,481 Cr | 5,842 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for IPCALAB?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in